REMERONSOLTAB
Drug
Organon LLC
Total Payments
$45,288
Transactions
5
Doctors
2
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $45,288 | 5 | 2 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $45,288 | 5 | 100.0% |
Ad
Manufacturing Companies
- Organon LLC $45,288
Product Information
- Type Drug
- Total Payments $45,288
- Total Doctors 2
- Transactions 5
About REMERONSOLTAB
REMERONSOLTAB is a drug associated with $45,288 in payments to 2 healthcare providers, recorded across 5 transactions in the CMS Open Payments database. The primary manufacturer is Organon LLC.
Payment data is available from 2022 to 2022. In 2022, $45,288 was paid across 5 transactions to 2 doctors.
The most common payment nature for REMERONSOLTAB is "Consulting Fee" ($45,288, 100.0% of total).